TickerFacts.

Unicycive Therapeutics, Inc. (UNCY): Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Revenue is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$675.0K
Year ended 2023-12-31
$951.0K2022-12-31: $951.0K2023-12-31: $675.0K$675.0K
2022-12-31 Revenue (USD) 2023-12-31
Period endedRevenueChange YoYSource filing
2023-12-31$675.0K-29.0%2025-03-31, From 2023-01-01
2022-12-31$951.0Kn/a2024-03-28, From 2022-01-01